Of all the cases of economic espionage charged by the DOJ's National Security Division since 2012, more than 80% of them implicated China.World Politicsread more
Removing Neumann is a difficult decision for Son, who has long believed in WeWork and Neumann's vision to quickly expand the company.Technologyread more
In his new memoir, "The Ride of a Lifetime," Iger explains why he decided against the deal to buy Twitter.Technologyread more
"Whilst there is a big dispute at the moment, I think there's also potential for resolution," UBS chairman Axel Weber says of the U.S.-China trade negotiations.Singapore Summitread more
No quid pro quo, there was nothing," Trump said the call. "It was a perfect conversation."Politicsread more
On Sunday, the 71st Primetime Emmy Awards honored the best comedies, dramas, limited and variety series from the last year.Entertainmentread more
Cryptocurrency fans will hope the futures contracts, which are federally regulated, can provide some much-needed legitimacy to bitcoin.Cryptocurrencyread more
Despite mixed fan and critic reactions to the final season of "Game of Thrones," the eight-season epic took home the top prize in the drama category at the Emmy Awards on...Entertainmentread more
There are alternative financial centers and investors can turn to Singapore, Tokyo or Shanghai if Hong Kong doesn't "shape up," says the founder and chairman of Citic Capital.Singapore Summitread more
The Kingdom and oil and gas industry have been slow to shore up defenses, raising red flags about the possibility of longer term fall-out in the region.Technologyread more
Tensions between South Korea and Japan may ultimately disrupt the high-end tech sectors, says Heenam Choi, CEO at South Korea's sovereign wealth fund.Singapore Summitread more
Use of prescription opioids such as OxyContin or Vicodin fell at a record rate last year as the U.S. government cracks down on pharmacists and drugmakers that dispense the sometimes lethal painkillers, according to a report published Thursday.
Prescription opioid use in the U.S. was down 17% in 2018, marking the largest annual decline ever recorded, research firm IQVIA Institute for Human Data Science said. In 1992, prescription opioid use was at roughly 22 pain pills per U.S. adult per year and rose to a peak level of 72 pills per U.S. adult in 2011, IQVIA said. Since 2011, use has declined by 43% to 34 pills per adult.
The new data, unveiled in IQVIA's 2019 report on health-care trends, provides some hope for combating the nationwide opioid epidemic, which kills roughly 130 Americans every day. Just last month, a new study provided troubling news that the opioid crisis has led to a sharp increase in the death rate for overdoses by teens and young adults.
The Justice Department and U.S. lawmakers have been working to combat the epidemic, such as limiting painkiller prescriptions and punishing those seen as responsible for the epidemic.
On Wednesday, Sen. Elizabeth Warren, D-Mass., and House Oversight Committee Chairman Elijah Cummings, D-Md., unveiled a $100 billion proposal that would fund prevention services and provide resources to programs for those battling addiction and in recovery.
Last month, a former CEO of Rochester Drug Cooperative, one of the nation's largest drug distributors, was indicted on what prosecutors say are the first criminal charges against an executive of a drug company to stem from the opioid epidemic. In addition, the federal government reached a $20 million settlement with the company over its alleged role in the crisis.
Separately, federal prosecutors charged 60 doctors, pharmacists and other licensed medical professionals across five states in connection with illegally prescribing more than 32 million pain pills.
The indictments came as some 1,600 cases against OxyContin-maker Purdue Pharma and other opioid manufacturers are being consolidated and transferred before a judge in the Northern District of Ohio, and New York and other states begin their own massive legal fights.
The report Thursday showed prescriptions for lower-dose opioids remained stable, possibly because such painkillers are still perceived by physicians and patients as relatively safe, IQVIA said.
—CNBC's Meg Tirrell contributed to this report.
For more on investing in health-care innovation, click here to join CNBC at our Healthy Returns Summit in New York City on May 21.